Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
3 evidence topics · 2 sources
Imlifidase
Kidney transplantation in highly sensitized patients
- Manufacturer
- Hansa Biopharma
- Regulatory submission
- BLA submitted December 2025
- Last updated